Synaptogenix, Inc. reported earnings results for the full year ended December 31, 2021. For the full year, the company reported net loss was USD 12.61 million compared to USD 12.7 million a year ago. Basic loss per share from continuing operations was USD 2.51 compared to USD 12.03 a year ago.
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
4.1 USD | -1.68% | -9.89% | -39.68% |
15/05 | Synaptogenix, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
09/04 | Synaptogenix, Inc. acquired Unknown Stake in Psyga Bio Ltd from Cannasoul Analytics Ltd. | CI |
1st Jan change | Capi. | |
---|---|---|
-39.68% | 45.26L | |
+50.84% | 5.93TCr | |
+41.42% | 4.09TCr | |
-5.50% | 4.02TCr | |
-5.16% | 2.87TCr | |
+12.76% | 2.66TCr | |
-20.48% | 1.89TCr | |
+31.36% | 1.25TCr | |
+0.27% | 1.24TCr | |
+25.70% | 1.23TCr |
- Stock Market
- Equities
- SNPX Stock
- News Synaptogenix, Inc.
- Synaptogenix, Inc. Reports Earnings Results for the Full Year Ended December 31, 2021